6505--Contingency Medication Compounding Services

Agency: VETERANS AFFAIRS, DEPARTMENT OF
State: Federal
Type of Government: Federal
FSC Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
NAICS Category:
  • 325412 - Pharmaceutical Preparation Manufacturing
Posted Date: Feb 11, 2026
Due Date: Feb 18, 2026
Solicitation No: 36C25626Q0332
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
6505--Contingency Medication Compounding Services
Active
Contract Opportunity
Notice ID
36C25626Q0332
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
256-NETWORK CONTRACT OFFICE 16 (36C256)
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information View Changes
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
  • Updated Published Date: Feb 11, 2026 11:29 am CST
  • Original Published Date: Feb 06, 2026 12:55 pm CST
  • Updated Date Offers Due: Feb 18, 2026 03:00 pm CST
  • Original Date Offers Due: Feb 16, 2026 03:00 pm CST
  • Inactive Policy: Manual
  • Updated Inactive Date: Mar 05, 2026
  • Original Inactive Date: Mar 03, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
    Michael E. Debakey VAMC Houston , 77030
Description
RFQ 36C256260332 Question and Answer Reponses

The purpose of this amendment is to:
Answer questions submitted by contractors by the original deadline of12:00pm, 10 FEB 2026. See Below.
Extend the deadline for all RFQ submissions to 3:00pm, 18 FEB 2026.

Vendor 1
I wanted to clarify an item regarding the solicitation for Contingency Medication Compounding Services (36C25626Q0332). Will medications from 503B outsourcing facilities be accepted in addition to those from 503A compounding facilities?
Government response:
Yes, accepted as long as the 503B pharmacy licensed by the State or registered by the FDA.
Attachments/Links
Contact Information
Contracting Office Address
  • 715 SOUTH PEAR ORCHARD RD., PLAZA 1
  • RIDGELAND , MS 39157
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Feb 6, 2026[Combined Synopsis/Solicitation (Updated)] 6505--Contingency Medication Compounding Services
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.
View Sample Report Start Free Trial

See Also

6550--Lab - ABBOTT ARCHITECT ...

Follow 6550--Lab - ABBOTT ARCHITECT REAGENTS AND CONSUMABLES Active Contract Opportunity Notice ID

VETERANS AFFAIRS, DEPARTMENT OF

Due by 11/12/2026

Epinephrine Injector

Follow Epinephrine Injector Active Contract Opportunity Notice ID SPE2D2-26-R-0009 Related Notice SPE2D2-26-R-0009 Department/Ind.

DEPT OF DEFENSE

Due by 11/16/2026

Annual Contract for Ear Plugs

Bid Number Bid Title Bid Type Organization Bid Issue Date Bid Close Date

San Antonio Water System

Due by 11/10/2026

DLA Medical Equipment Electro...

Follow DLA Medical Equipment Electronic CATalog (ECAT) Generation V Program Active Contract Opportunity

DEPT OF DEFENSE

Due by 12/01/2026

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.